Lyell Immunopharma, Inc.LYELNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
87.50%
↓ 100% below average
Average (22q)
70407.41%
Historical baseline
Range
High:1612766.67%
Low:-99.99%
Volatility
2290.8%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 87.50% |
| Q2 2025 | 14.29% |
| Q1 2025 | -36.36% |
| Q4 2024 | -67.65% |
| Q3 2024 | 161.54% |
| Q2 2024 | 333.33% |
| Q1 2024 | -76.92% |
| Q4 2023 | -48.00% |
| Q3 2023 | -7.41% |
| Q2 2023 | -58.46% |
| Q1 2023 | -99.87% |
| Q4 2022 | 1612766.67% |
| Q3 2022 | -99.99% |
| Q2 2022 | 6363.11% |
| Q1 2022 | -80.40% |
| Q4 2021 | 2.43% |
| Q3 2021 | 4.83% |
| Q2 2021 | 7.48% |
| Q1 2021 | 5.75% |
| Q4 2020 | 116.07% |
| Q3 2020 | -65.68% |
| Q2 2020 | 148.25% |
| Q1 2020 | 0.00% |